Latest filing published 24 Oct 2025 for KALA BIO, Inc., €34k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Todd Bazemore (senior executive) discloses dealings in 2 companies, chiefly KALA BIO, Inc. and Dyax Corp. The record holds 16 filings, for trades running from 22 January 2016 to 22 October 2025.
No open-market purchase appears, only 10 sales worth €132k. The rest of the record consists of 5 share grants. So far in 2025, the count stands at no purchases and 3 sales.
Most recently, on 24 October 2025, the filings show an open-market sale worth €34k in KALA BIO, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations